Multiple biological blockbusters, with cumulative sales of more than $50 billion, will be coming off-patent over next five years.

Celonic has been dedicated to the development and production of biosimilars for many years and is part of "The Biosimilars Group" expert network. Over the years, Celonic has developed strong know-how and expertise of biosimilar products and process development.

We are well positioned to give our clients a head start in the highly competitive biosimilars market.

  • Celonic offers ready to go Biosimilar (Cell lines and cell pools - Comprehensive analytics methods - Comparability data - Development process)
  • Commitment to ongoing co-development of next wave Biosimilars
  • Simplified and flexible commercial models (no royalties)
  • GMP production